Pluristem Therapeutics Inc. (Nasdaq: PSTI) increased its previously announced bought deal to $15 million. The stock price fell 25 cents to close at $1.15.
Pluristem Therapeutics increases bought deal
January 20, 2017 at 16:14 PM EST
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.